U.S. Senator Susan Collins on Addressing Rising Drug Prices

Webcast: A Senate leader shares insights on how to tackle growing prescription drug costs

Event
Share
Twitter
Facebook
LinkedIn
Email
Print
U.S. Senator Susan Collins on Addressing Rising Drug Prices
U.S. Senator Susan Collins on Addressing Rising Drug Prices

Addressing skyrocketing drug prices is a priority for Senator Susan Collins (R-ME), who has earned a national reputation for working across party lines to advance evidence-based solutions to pressing policy issues during 20 years in office. She has championed bipartisan measures in Congress to increase the affordability and accessibility of prescription drugs and led the Senate’s landmark 2015 bipartisan investigation into the rising prices of off-patent prescription drugs. Legislation she introduced to improve generic drug competition, and reduce costs, became law in 2017.

On Monday, July 16, Senator Collins spoke at The Pew Charitable Trusts and discussed her efforts to reduce Americans’ prescription drug expenses and ensure that patients have access to needed therapies.

For insights, statistics, and commentary from the event, see the conversation on #SenCollinsatPew.

Senator Susan Collins on Martin Shkreli and Rising U.S. Drug Costs
Republican Senator Susan Collins of Maine explains what former hedge fund manager Martin Shkreli symbolizes when it comes to high prescription drug costs.
Senator Susan Collins: Bipartisanship Key to Lower U.S. Drug Costs
How can we tackle rising drug prices? Bipartisan cooperation and hard work, says Republican Senator Susan Collins of Maine at a Pew Charitable Trusts event.
Senator Susan Collins Addresses the High Cost of Prescriptions 
“Follow the money,” says Republican Senator Susan Collins of Maine, when it comes to figuring out who is profiting from expensive drug prices—and what the real price should be.